Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:irbesartan
|
| gptkbp:approvedBy |
gptkb:European_Union
|
| gptkbp:ATCCode |
C09CA04
|
| gptkbp:contraindication |
pregnancy
severe hepatic impairment |
| gptkbp:drugClass |
angiotensin II receptor blocker
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aprovel
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Sanofi
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
hypotension hyperkalemia |
| gptkbp:usedFor |
hypertension
diabetic nephropathy |
| gptkbp:bfsParent |
gptkb:Sanofi-Aventis
|
| gptkbp:bfsLayer |
6
|